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E. Choke
Leicester Royal Inﬁrmary, Leicester, UKDeath from abdominal aortic aneurysm (AAA) rupture can
be signiﬁcantly lowered through single screening with ul-
trasound scan in men aged 65e74 years. Nevertheless, AAA
screening is not without risks. It is therefore a mandatory
requirement that AAA screening programmes inform po-
tential participants of any possible adverse outcomes. In the
UK the National Health Service Abdominal Aortic Aneurysm
Screening Program summarises the risks involved clearly
and unambiguously in its standard national information
leaﬂet sent to all men on invitation.
Historically, there were concerns over the implementa-
tion of a national AAA screening programme in the UK
owing to high mortality after elective AAA repair (7.5%d
double the average for the rest of Europe). Following an
agreed action plan to reduce mortality from elective AAA
repair through a quality improvement framework consisting
of best practice standards for aortic surgery,1 the 30-day
mortality after elective AAA surgery improved to 2.4%. It
is imperative that the low mortality be maintained so that
AAA screening will continue to be effective.
In this issue, Linne et al. compared postoperative mor-
tality and morbidity between patients with screen-
detected versus nonscreen-detected AAAs.2 They re-
ported low postoperative mortality after AAA surgery and
their data revealed no differences in postoperative mor-
tality (at 30 days, 90 days, and 1 year) or morbidity be-
tween patients with screen-detected AAAs and age-
matched controls. The effectiveness of AAA screening is
clearly dependent on the safe management of any AAA
detected, and the low postoperative mortality and
morbidity in screen-detected AAA patients from the
Swedish National Registry for Vascular Surgery (Swedvasc)
are therefore very encouraging.
Linne et al. postulated that nonscreen-detected male
patients with AAA will have more comorbidities that those
detected through screening.2 Intuitively, this would seem
reasonable, and Linne et al. suggested that nonscreened
patients are more likely to be demographicallyDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.08.024
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http://dx.doi.org/10.1016/j.ejvs.2014.10.016disadvantaged towards lower levels of education and lower
incomes,2 and also therefore more likely to be smokers and
recent immigrants, with higher frequencies of stroke, dia-
betes, chronic obstructive pulmonary disease, and renal
failure. The authors also reasoned that as nonscreen-
detected AAAs are often detected incidentally through in-
vestigations for other diseases, they are therefore also more
likely to have a higher disease burden. If this is true, then
“healthier” screen-detected AAAs should demonstrate bet-
ter postoperative outcomes.
However, data from the Swedvasc revealed no differ-
ences in comorbidities (besides lower age) in the screen-
detected group than in the nonscreen-detected group.
This could explain why patients with screen-detected AAAs
demonstrated no superiority in postoperative outcomes
compared with age matched patients with nonscreen-
detected AAAs. Further analyses also failed to detect any
differences in postoperative mortality between patients
with screened-detected AAAs and all patients with
nonscreened-detected AAAs (not age matched). These
ﬁndings are in contrast to meta-analyses of four randomised
controlled trials of AAA screening (supplemented by data
from the Viborg Vascular screening trial),3 in which the risk
to men with a screen-detected AAA of 30-day death was
one-third of that of men with an incidentally detected
aneurysm. However, it is important to point out that when
the data from the meta-analyses were controlled for age, no
30-day survival advantage was demonstrated in the group
with screen-detected AAAs.
The lack of any survival advantage in the group with
screen-detected AAAs from the Swedvasc data should not
necessarily detract from the beneﬁcial effect of screening
for AAAs. If anything, the very low postoperative mortality
gives further support to national screening programs for the
detection of AAAs in men and for a more widespread in-
ternational adoption of AAA screening.
In terms of future work, factors to be considered other
than the length of life are the postscreening quality of lives
of participants. It is a recognised fact that in a minority of
individuals the quality of life can be negatively affected by
AAA screening; if this is true, perhaps support, as clinically
indicated, may be a necessary feature of AAA screening
programmes.
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